# Chronic Subdural Hematoma and Aspirin

> **NCT03120182** · NA · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 150 (actual)

## Conditions studied

- Chronic Subdural Hematoma

## Interventions

- **DRUG:** Acetylsalicylic acid
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03120182
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-19
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2024-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03120182

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03120182, "Chronic Subdural Hematoma and Aspirin". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03120182. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*